Ironwood Pharmaceuticals (NASDAQ:IRWD) reported earnings of ($0.14) per share beating Walls Streets expectations.

Ironwood Pharmaceuticals (NASDAQ:IRWD) reported Q4 2017 earnings this Afternoon, coming in at ($0.14) per share, beating Wall Street’s estimates of ($0.18) per Share. Revenue for the quarter came in at $94.20 million beating analyst estimates of $88.86 million

Recent Insider Trading for Ironwood Pharmaceuticals (NASDAQ:IRWD)

  • On 1/24/2018 Mark G Currie, Insider, sold 60,000 with an average share price of $15.45 per share and the total transaction amounting to $927,000.00.
  • On 12/7/2017 Peter M Hecht, CEO, sold 113,405 with an average share price of $15.12 per share and the total transaction amounting to $1,714,683.60.
  • On 12/4/2017 Julie Mchugh, Director, sold 1,500 with an average share price of $16.45 per share and the total transaction amounting to $24,675.00.
  • On 11/10/2017 Gina Consylman, CFO, sold 864 with an average share price of $15.20 per share and the total transaction amounting to $13,132.80.
  • On 9/5/2017 Julie Mchugh, Director, sold 1,500 with an average share price of $16.16 per share and the total transaction amounting to $24,240.00.
  • On 8/18/2017 Gina Consylman, Insider, sold 207 with an average share price of $14.34 per share and the total transaction amounting to $2,968.38.



    Recent Trading for Ironwood Pharmaceuticals (NASDAQ:IRWD)
    Shares of Ironwood Pharmaceuticals closed the previous trading session at 15.36 up +0.87 6.00% with 15.569999694824219 shares trading hands.

    An ad to help with our costs